Abstract:Introduction Outflow graft stenosis (OGS) has been reported in patients with the HeartMate 3 left ventricular assist device (LVAD) as a result of biodebris accumulation outside the graft. As a result, patients may experience unexpected low-flow alarms, relapse of heart failure symptoms, cardiogenic shock, or even death. Different cutoff values are used to define OGS, and the literature also lacks clarity regarding how the severity of OGS relates to potential clinical outcomes. Purpose The purpose of this study is to describe the prevalence, clinical presentation, outcomes, and treatments associated with different degrees of HeartMate 3 LVAD OGS. Methods In this single-centre retrospective cohort study, we reviewed all HeartMate 3 patients between March 2016 and December 2023 with an available computed tomographic angiogram (CTA) sufficient to assess the outflow graft lumen. Before 2022, CTAs were conducted only at baseline after LVAD implantation and on specific indications, such as low-flow alarms. However, since 2022, routine biennial CTAs have been performed for all patients, starting 2 years post-LVAD implantation, reflecting increased awareness of LVAD OGS. We determined the percentage of lumen narrowing by measuring perpendicular to the outflow graft in different axes, categorizing as: no stenosis (0-25%), mild stenosis (25-50%), moderate stenosis (50-75%), and severe stenosis (>75%). Results We included 135 patients (median age: 53 years, 63% male), with a total of 330 available CTA scans. Throughout the study period (median FU of 31.8 months, IQR:11-43), evidence of OGS was observed in 16 (11.8%) patients: 8 (5.9%) with mild stenosis, 6 (4.4%) with moderate stenosis, and 2 (1.5%) with severe stenosis. The median time to mild stenosis, moderate stenosis, and severe stenosis was 2.5, 3.9, and 4.9 years respectively. Figure illustrates the prevalence, clinical presentation and treatment of various degrees of OGS. Among patients with mild stenosis, 75% (6/8) were detected incidentally during routine CTA scans, while 50% (3/6) of those with moderate stenosis presented with low-flow alarms. Only 7.6% (9/119) of patients with no stenosis experienced low-flow alarms. Mild and moderate stenosis were not associated with mortality compared to no stenosis (p>0.05), but severe stenosis was (p<0.05). Five patients underwent stenting, and one patient underwent surgery for outflow graft stenosis. Conclusions LVAD OGS is a significant late complication affecting approximately one in eight patients, with potentially severe consequences. Severe stenosis is associated with higher mortality compared to no stenosis. The true prevalence may be underestimated due to delayed radiological surveillance initiation. CTA plays a pivotal role as a non-invasive diagnostic step to identify OGS and systematic screening may be warranted. Endovascular stenting or surgery can effectively treat patients with OGS.

Outcomes of outflow graft stenting in HeartMate 3 left ventricular assist devices: A systematic review and individual patient data meta‐analysis

Outflow graft stenosis after left ventricular assist device implantation: the rotterdam experience

Outflow graft obstruction after left ventricular assist device implantation: a retrospective, single-centre case series

Outflow graft obstruction in patients with the HM 3 LVAD: A percutaneous approach

Percutaneous Stenting Of The Bend Relief And Proximal Segment Outflow Graft Of Durable Left Ventricular Assisted Device

Extrinsic Outflow Graft Obstruction of the HeartMate 3 LVAD: A State-of-the-Art Review

Haemodynamic significance of extrinsic outflow graft stenoses during HeartMate 3™ therapy

Outflow Graft Tamponade: An Underrecognized Cause of Obstruction

A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device

Percutaneous endovascular intervention for left ventricular assist device outflow graft obstruction: A single-center experience

Surgical intervention for left ventricular assist device outflow graft obstruction due to external compression

Nine Years of Continuous Flow LVAD (HeartMate 3): Survival and LVAD-Related Complications before and after Hospital Discharge

Efficacy of Primary Stent-Graft Placement in the Treatment of Vascular Access Graft Outflow Tract Stenosis

Enhancing the implantation of mechanical circulatory support devices using computational simulations

Multilayer Flow Modulator Stent for Aortic Pathology: A Meta-Analysis and Additional Data from a Single-Centre Retrospective Cohort

Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type

HeartMate 3: Analysis of Outcomes and Future Directions

Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival

Outcomes and Complications after Left Ventricular Assist Device Implantation

Influence of the Outflow Graft Angular Position on the Outcomes in Patients With a Left Ventricular Assist Device

HeartMate 3 implantation with an emphasis on the biventricular configuration